Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-12-000246
Filing Date
2012-04-02
Accepted
2012-04-02 15:28:14
Documents
1
Period of Report
2012-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 16402
  Complete submission text file 0000914190-12-000246.txt   17880
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NILE THERAPEUTICS INC. 115 SANSOME ST., SUITE 310 SAN FRANCISCO CA 94104
Business Address
Lieu Hsiao (Reporting) CIK: 0001468482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 12733078